-
13:00
-13:15
Prognostic value of circulating tumor DNA residual disease after primary debulking surgery for ovarian cancer
-
13:15
-13:30
Clinical application of hyperthermic intraperitoneal chemotherapy during interval debulking of advanced ovarian cancer
-
13:30
-13:45
The correlation between serum signature and prognosis in ovarian cancer
-
13:45
-14:00
Q&A

